Lipid Modification Database
Tag Content
LipidDB ID
LipidDB-10090-00952
Entry Name
UniProt Accession
Theoretical PI
4.71
Molecular Weight
86722.05
Genbank Protein ID
Genbank Nucleotide ID
Protein Name
C31
Protein Synonyms/Alias
ABPP; APP; Alzheimer disease amyloid A4 protein homolog; Amyloidogenic glycoprotein; AG; S-APP-alpha; S-APP-beta; APP-C99; Beta-APP42; Beta-APP40; APP-C59; Amyloid intracellular domain 59; AID(59); Gamma-CTF(59); APP-C57; Amyloid intracellular domain 57; AID(57); Gamma-CTF(57); Amyloid intracellular domain 50; AID(50); Gamma-CTF(50);
Gene Name
App
Gene Synonyms/Alias
Created Date
01-OCT-1989
 Lipid Modification Sites 
 Position   Sequence Form   Peptide   References   Modification Type 
186
Canonical
FRGVEFVCCPLAEES
[1]
S-Palmitoylation
187
Canonical
RGVEFVCCPLAEESD
[1]
S-Palmitoylation
Organism
Mus musculus (Mouse)
NCBI Taxa ID
10090
Reference
[1] Bhattacharyya R, Barren C, Kovacs DM. Palmitoylation of amyloid precursorprotein regulates amyloidogenic processing in lipid rafts. J Neurosci. 2013 Jul3;33(27):11169-83. doi: 10.1523/JNEUROSCI.4704-12.2013.[PMID:23825420]
Functional Description
Functions as a cell surface receptor and performs physiological functions on the surface of neurons relevant to neurite growth, neuronal adhesion and axonogenesis. Involved in cell mobility and transcription regulation through protein-protein interactions. Can promote transcription activation through binding to APBB1-KAT5 and inhibit Notch signaling through interaction with Numb. Couples to apoptosis-inducing pathways such as those mediated by G(O) and JIP. Inhibits G(o) alpha ATPase activity (By similarity). Acts as a kinesin I membrane receptor, mediating the axonal transport of beta-secretase and presenilin 1. May be involved in copper homeostasis/oxidative stress through copper ion reduction. Can regulate neurite outgrowth through binding to components of the extracellular matrix such as heparin and collagen I and IV (By similarity). The splice isoforms that contain the BPTI domain possess protease inhibitor activity. Induces a AGER-dependent pathway that involves activation of p38 MAPK, resulting in internalization of amyloid-beta peptide and leading to mitochondrial dysfunction in cultured cortical neurons (By similarity). Provides Cu(2+) ions for GPC1 which are required for release of nitric oxide (NO) and subsequent degradation of the heparan sulfate chains on GPC1.
Sequence Annotation
Topological domain: 18 699 Extracellular.
Transmembrane: 700 723 Helical.
Topological domain: 724 770 Cytoplasmic.
Domain: 291 341 BPTI/Kunitz inhibitor.
Region: 96 110 Heparin-binding.
Region: 181 188 Zinc-binding.
Region: 391 423 Heparin-binding.
Region: 491 522 Heparin-binding.
Region: 523 540 Collagen-binding.
Region: 732 751 Interaction with G(o)-alpha.
Region: 756 770 Interaction with DAB2.
Motif: 724 734 Basolateral sorting signal.
Motif: 759 762 NPXY motif; contains endocytosis signal.
Metal binding site: 147 147 Copper 1.
Metal binding site: 151 151 Copper 1.
Metal binding site: 168 168 Copper 1.
Metal binding site: 677 677 Copper or zinc 2.
Metal binding site: 685 685 Copper or zinc 2.
Functional site: 144 144 Required for Cu(2+) reduction.
Functional site: 301 302 Reactive bond.
Functional site: 671 672 Cleavage; by beta-secretase.
Functional site: 672 673 Cleavage; by caspase-6.
Functional site: 687 688 Cleavage; by alpha-secretase.
Functional site: 690 691 Cleavage; by theta-secretase.
Functional site: 704 704 Implicated in free radical propagation.
Functional site: 711 712 Cleavage; by gamma-secretase; site 1.
Functional site: 713 714 Cleavage; by gamma-secretase; site 2.
Functional site: 720 721 Cleavage; by gamma-secretase; site 3.
Functional site: 739 740 Cleavage; by caspase-6, caspase-8 orcaspase-9.
Modified residue: 198 198 Phosphoserine; by CK2.
Modified residue: 206 206 Phosphoserine; by CK1.
Modified residue: 729 729 Phosphothreonine.
Modified residue: 730 730 Phosphoserine; by APP-kinase I.
Modified residue: 743 743 Phosphothreonine; by CDK5 and MAPK10.
Modified residue: 757 757 Phosphotyrosine; by ABL1.
Protein Length
770 AA.
Protein Sequence
(Canonical)
MLPSLALLLL AAWTVRALEV PTDGNAGLLA EPQIAMFCGK LNMHMNVQNG KWESDPSGTK  60
TCIGTKEGIL QYCQEVYPEL QITNVVEANQ PVTIQNWCKR GRKQCKTHTH IVIPYRCLVG  120
EFVSDALLVP DKCKFLHQER MDVCETHLHW HTVAKETCSE KSTNLHDYGM LLPCGIDKFR  180
GVEFVCCPLA EESDSVDSAD AEEDDSDVWW GGADTDYADG GEDKVVEVAE EEEVADVEEE  240
EADDDEDVED GDEVEEEAEE PYEEATERTT STATTTTTTT ESVEEVVREV CSEQAETGPC  300
RAMISRWYFD VTEGKCVPFF YGGCGGNRNN FDTEEYCMAV CGSVSTQSLL KTTSEPLPQD  360
PDKLPTTAAS TPDAVDKYLE TPGDENEHAH FQKAKERLEA KHRERMSQVM REWEEAERQA  420
KNLPKADKKA VIQHFQEKVE SLEQEAANER QQLVETHMAR VEAMLNDRRR LALENYITAL  480
QAVPPRPHHV FNMLKKYVRA EQKDRQHTLK HFEHVRMVDP KKAAQIRSQV MTHLRVIYER  540
MNQSLSLLYN VPAVAEEIQD EVDELLQKEQ NYSDDVLANM ISEPRISYGN DALMPSLTET  600
KTTVELLPVN GEFSLDDLQP WHPFGVDSVP ANTENEVEPV DARPAADRGL TTRPGSGLTN  660
IKTEEISEVK MDAEFGHDSG FEVRHQKLVF FAEDVGSNKG AIIGLMVGGV VIATVIVITL  720
VMLKKKQYTS IHHGVVEVDA AVTPEERHLS KMQQNGYENP TYKFFEQMQN             770
FASTA
(Canonical)
>LipidDB-10090-00952|P12023
MLPSLALLLLAAWTVRALEVPTDGNAGLLAEPQIAMFCGKLNMHMNVQNGKWESDPSGTK
TCIGTKEGILQYCQEVYPELQITNVVEANQPVTIQNWCKRGRKQCKTHTHIVIPYRCLVG
EFVSDALLVPDKCKFLHQERMDVCETHLHWHTVAKETCSEKSTNLHDYGMLLPCGIDKFR
GVEFVCCPLAEESDSVDSADAEEDDSDVWWGGADTDYADGGEDKVVEVAEEEEVADVEEE
EADDDEDVEDGDEVEEEAEEPYEEATERTTSTATTTTTTTESVEEVVREVCSEQAETGPC
RAMISRWYFDVTEGKCVPFFYGGCGGNRNNFDTEEYCMAVCGSVSTQSLLKTTSEPLPQD
PDKLPTTAASTPDAVDKYLETPGDENEHAHFQKAKERLEAKHRERMSQVMREWEEAERQA
KNLPKADKKAVIQHFQEKVESLEQEAANERQQLVETHMARVEAMLNDRRRLALENYITAL
QAVPPRPHHVFNMLKKYVRAEQKDRQHTLKHFEHVRMVDPKKAAQIRSQVMTHLRVIYER
MNQSLSLLYNVPAVAEEIQDEVDELLQKEQNYSDDVLANMISEPRISYGNDALMPSLTET
KTTVELLPVNGEFSLDDLQPWHPFGVDSVPANTENEVEPVDARPAADRGLTTRPGSGLTN
IKTEEISEVKMDAEFGHDSGFEVRHQKLVFFAEDVGSNKGAIIGLMVGGVVIATVIVITL
VMLKKKQYTSIHHGVVEVDAAVTPEERHLSKMQQNGYENPTYKFFEQMQN
Gene Ontology
GO:0045177; C:apical part of cell; IDA:MGI
GO:0030424; C:axon; IDA:MGI
GO:0009986; C:cell surface; IEA:Ensembl
GO:0005911; C:cell-cell junction; IDA:MGI
GO:0035253; C:ciliary rootlet; IDA:MGI
GO:0005905; C:coated pit; IEA:UniProtKB-KW
GO:0005737; C:cytoplasm; IDA:MGI
GO:0031410; C:cytoplasmic vesicle; IDA:MGI
GO:0043198; C:dendritic shaft; IEA:Ensembl
GO:0043197; C:dendritic spine; IEA:Ensembl
GO:0030134; C:ER to Golgi transport vesicle; IDA:MGI
GO:0005615; C:extracellular space; IEA:Ensembl
GO:0070062; C:extracellular vesicular exosome; IEA:Ensembl
GO:0005794; C:Golgi apparatus; IDA:MGI
GO:0016021; C:integral component of membrane; IDA:MGI
GO:0016020; C:membrane; IDA:MGI
GO:0045121; C:membrane raft; IEA:Ensembl
GO:0031594; C:neuromuscular junction; IDA:MGI
GO:0043005; C:neuron projection; IDA:MGI
GO:0005641; C:nuclear envelope lumen; IEA:Ensembl
GO:0048471; C:perinuclear region of cytoplasm; IDA:MGI
GO:0005886; C:plasma membrane; IDA:MGI
GO:0043235; C:receptor complex; ISO:MGI
GO:0051233; C:spindle midzone; IDA:MGI
GO:0003677; F:DNA binding; IDA:MGI
GO:0008201; F:heparin binding; IEA:UniProtKB-KW
GO:0016504; F:peptidase activator activity; IEA:Ensembl
GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
GO:0046914; F:transition metal ion binding; IEA:InterPro
GO:0008344; P:adult locomotory behavior; IMP:MGI
GO:0008088; P:axon cargo transport; IMP:MGI
GO:0016199; P:axon midline choice point recognition; IMP:MGI
GO:0007409; P:axonogenesis; IMP:MGI
GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
GO:0006878; P:cellular copper ion homeostasis; IMP:MGI
GO:0008203; P:cholesterol metabolic process; IMP:MGI
GO:0048669; P:collateral sprouting in absence of injury; IGI:MGI
GO:0016358; P:dendrite development; IMP:MGI
GO:0006897; P:endocytosis; IMP:MGI
GO:0030198; P:extracellular matrix organization; IGI:MGI
GO:0030900; P:forebrain development; IMP:MGI
GO:0035235; P:ionotropic glutamate receptor signaling pathway; IMP:MGI
GO:0007626; P:locomotory behavior; IGI:MGI
GO:0007617; P:mating behavior; IGI:MGI
GO:0006378; P:mRNA polyadenylation; IDA:MGI
GO:0045665; P:negative regulation of neuron differentiation; IDA:MGI
GO:0050885; P:neuromuscular process controlling balance; IGI:MGI
GO:0051402; P:neuron apoptotic process; IGI:MGI
GO:0031175; P:neuron projection development; IDA:MGI
GO:0016322; P:neuron remodeling; IMP:MGI
GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW
GO:0010971; P:positive regulation of G2/M transition of mitotic cell cycle; IMP:MGI
GO:0045931; P:positive regulation of mitotic cell cycle; IMP:MGI
GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI
GO:0051260; P:protein homooligomerization; ISO:MGI
GO:0006468; P:protein phosphorylation; IMP:MGI
GO:0007176; P:regulation of epidermal growth factor-activated receptor activity; IGI:MGI
GO:0010468; P:regulation of gene expression; IDA:MGI
GO:0040014; P:regulation of multicellular organism growth; IMP:MGI
GO:0043393; P:regulation of protein binding; IMP:MGI
GO:0050803; P:regulation of synapse structure and activity; IMP:MGI
GO:0006417; P:regulation of translation; IDA:MGI
GO:0006979; P:response to oxidative stress; IGI:MGI
GO:0051563; P:smooth endoplasmic reticulum calcium ion homeostasis; IGI:MGI
GO:0001967; P:suckling behavior; IGI:MGI
GO:0051124; P:synaptic growth at neuromuscular junction; IGI:MGI
GO:0008542; P:visual learning; IMP:MGI
Interpro
InterPro; IPR008155; Amyloid_glyco
InterPro; IPR013803; Amyloid_glyco_Abeta
InterPro; IPR011178; Amyloid_glyco_Cu-bd
InterPro; IPR024329; Amyloid_glyco_E2_domain
InterPro; IPR008154; Amyloid_glyco_extra
InterPro; IPR019744; Amyloid_glyco_extracell_CS
InterPro; IPR015849; Amyloid_glyco_heparin-bd
InterPro; IPR019745; Amyloid_glyco_intracell_CS
InterPro; IPR028866; APP
InterPro; IPR019543; APP_amyloid_C
InterPro; IPR002223; Prot_inh_Kunz-m
InterPro; IPR020901; Prtase_inh_Kunz-CS
Pfam
Pfam; PF10515; APP_amyloid;
Pfam; PF12924; APP_Cu_bd;
Pfam; PF12925; APP_E2;
Pfam; PF02177; APP_N;
Pfam; PF03494; Beta-APP;
Pfam; PF00014; Kunitz_BPTI;
SMART
SMART; SM00006; A4_EXTRA;
SMART; SM00131; KU;
PROSITE
PROSITE; PS00319; A4_EXTRA;
PROSITE; PS00320; A4_INTRA;
PROSITE; PS00280; BPTI_KUNITZ_1;
PROSITE; PS50279; BPTI_KUNITZ_2;
PRINTS
PRINTS; PR00203; AMYLOIDA4;
PRINTS; PR00759; BASICPTASE;
PRINTS; PR00204; BETAAMYLOID;